These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 19813275

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
    Gallegos-Castorena S, Martínez-Avalos A, Mohar-Betancourt A, Guerrero-Avendaño G, Zapata-Tarrés M, Medina-Sansón A.
    Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
    [Abstract] [Full Text] [Related]

  • 23. Combined carboplatin and cisplatin. Limited prospects for dose intensification.
    Waterhouse DM, Reynolds RK, Natale RB.
    Cancer; 1993 Jun 15; 71(12):4060-6. PubMed ID: 8508371
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
    Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.
    Cancer; 2017 Jun 15; 123(12):2360-2367. PubMed ID: 28211941
    [Abstract] [Full Text] [Related]

  • 26. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
    Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA.
    J Clin Oncol; 2008 May 10; 26(14):2379-83. PubMed ID: 18467729
    [Abstract] [Full Text] [Related]

  • 27. Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.
    Rick O, Beyer J, Schwella N, Schubart H, Schleicher J, Siegert W.
    Ann Oncol; 2001 Aug 10; 12(8):1151-5. PubMed ID: 11583199
    [Abstract] [Full Text] [Related]

  • 28. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G, Shafford E, Maibach R, Aronson D, Brugières L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte JB, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J, International Society of Paediatric Oncology-SIOPEL 2.
    Eur J Cancer; 2004 Feb 10; 40(3):411-21. PubMed ID: 14746860
    [Abstract] [Full Text] [Related]

  • 29. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S, Hoffmanns H.
    Strahlenther Onkol; 1999 Nov 10; 175 Suppl 4():30-3. PubMed ID: 10584138
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 10; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
    Dean JB, Hayashi SS, Albert CM, King AA, Karzon R, Hayashi RJ.
    J Pediatr Hematol Oncol; 2008 Feb 10; 30(2):130-4. PubMed ID: 18376265
    [Abstract] [Full Text] [Related]

  • 35. Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.
    Betticher DC, Anderson H, Ranson M, Meely K, Oster W, Thatcher N.
    Br J Cancer; 1995 Dec 10; 72(6):1551-5. PubMed ID: 8519676
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
    Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D, Glick J.
    J Clin Oncol; 1996 Jul 10; 14(7):2101-12. PubMed ID: 8683243
    [Abstract] [Full Text] [Related]

  • 38. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.
    Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ.
    J Clin Oncol; 2011 Aug 20; 29(24):3301-6. PubMed ID: 21768450
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2016 Aug 08; (8):CD010885. PubMed ID: 27498707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.